Access the full text.
Sign up today, get DeepDyve free for 14 days.
Celia Morgan, Gra´inne, Tom Schafer, Freeman Valerie, Curran (2010)Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study
British Journal of Psychiatry, 197
A. Zuardi (2006)History of cannabis as a medicine: a review.
Revista brasileira de psiquiatria, 28 2
Aline Quartilho, H. Mata, Mohab Ibrahim, Todd Vanderah, F. Porreca, A. Makriyannis, T. Malan (2003)Inhibition of Inflammatory Hyperalgesia by Activation of Peripheral CB2 Cannabinoid Receptors
R. Pertwee, A. Howlett, M. Abood, Stephen Alexander, V. Marzo, M. Elphick, P. Greasley, H. Hansen, G. Kunos, K. Mackie, R. Mechoulam, R. Ross (2010)International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2
Pharmacological Reviews, 62
D. Cichewicz, Erin Mccarthy (2003)Antinociceptive Synergy between Δ9-Tetrahydrocannabinol and Opioids after Oral Administration
Journal of Pharmacology and Experimental Therapeutics, 304
C. Gérard, C. Mollereau, G. Vassart, M. Parmentier (1991)Molecular cloning of a human cannabinoid receptor which is also expressed in testis.
The Biochemical journal, 279 ( Pt 1)
T. Burns, J. Ineck (2006)Cannabinoid Analgesia as a Potential New Therapeutic Option in the Treatment of Chronic Pain
Annals of Pharmacotherapy, 40
A. Nackley, A. Zvonok, A. Makriyannis, A. Hohmann (2004)Activation of cannabinoid CB2 receptors suppresses C-fiber responses and windup in spinal wide dynamic range neurons in the absence and presence of inflammation.
Journal of neurophysiology, 92 6
J. Walker, Susan Huang (2002)Cannabinoid analgesia.
Pharmacology & therapeutics, 95 2
M. Jhaveri, S. Elmes, D. Richardson, David Barrett, Dave Kendall, Robert Mason, Victoria Chapman (2008)Evidence for a novel functional role of cannabinoid CB2 receptors in the thalamus of neuropathic rats
The European Journal of Neuroscience, 27
D. Rog, T. Nurmikko, T. Friede, C. Young (2005)Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis
S. Kozono, T. Matsuyama, Kamal Biwasa, K. Kawahara, Y. Nakajima, T. Yoshimoto, Yutaka Yonamine, H. Kadomatsu, S. Tancharoen, T. Hashiguchi, K. Noguchi, I. Maruyama (2010)Involvement of the endocannabinoid system in periodontal healing.
Biochemical and biophysical research communications, 394 4
(2009)Betacaryophyllene, a phytocannabinoid acting on CB2 receptors
D. Carley, Sasa Paviovic, M. Janelidze, M. Radulovacki (2002)Functional role for cannabinoids in respiratory stability during sleep.
Sleep, 25 4
Michael Lee, M. Ploner, K. Wiech, U. Bingel, V. Wanigasekera, J. Brooks, D. Menon, I. Tracey (2013)Amygdala activity contributes to the dissociative effect of cannabis on pain perception
M. Costigan, J. Scholz, C. Woolf (2009)Neuropathic pain: a maladaptive response of the nervous system to damage.
Annual review of neuroscience, 32
Ethan Russo (2011)Taming THC: potential cannabis synergy and phytocannabinoid‐terpenoid entourage effects
British Journal of Pharmacology, 163
M. Wallace, G. Schulteis, J. Atkinson, T. Wolfson, D. Lazzaretto, Heather Bentley, B. Gouaux, I. Abramson (2007)Dose-dependent Effects of Smoked Cannabis on Capsaicin-induced Pain and Hyperalgesia in Healthy Volunteers
Ethan Russo (2008)Cannabinoids in the management of difficult to treat pain
Therapeutics and Clinical Risk Management, 4
T. Romero, Lívia Resende, L. Guzzo, I. Duarte (2013)CB1 and CB2 Cannabinoid Receptor Agonists Induce Peripheral Antinociception by Activation of the Endogenous Noradrenergic System
Anesthesia & Analgesia, 116
U. Anand, W. Otto, D. Sánchez-Herrera, P. Facer, Y. Yiangou, Y. Korchev, R. Birch, C. Benham, C. Bountra, I. Chessell, P. Anand (2008)Cannabinoid receptor CB2 localisation and agonist-mediated inhibition of capsaicin responses in human sensory neurons
Z. Vogel, J. Barg, R. Levy, D. Saya, E. Heldman, R. Mechoulam (1993)Anandamide, a Brain Endogenous Compound, Interacts Specifically with Cannabinoid Receptors and Inhibits Adenylate Cyclase
Journal of Neurochemistry, 61
W. Devane, L. Hanuš, A. Breuer, R. Pertwee, L. Stevenson, G. Griffin, D. Gibson, A. Mandelbaum, A. Etinger, R. Mechoulam (1992)Isolation and structure of a brain constituent that binds to the cannabinoid receptor.
Science, 258 5090
B. Wilsey, T. Marcotte, R. Deutsch, B. Gouaux, Staci Sakai, Haylee Donaghe (2013)Low-dose vaporized cannabis significantly improves neuropathic pain.
The journal of pain : official journal of the American Pain Society, 14 2
K. Svendsen, T. Jensen, F. Bach (2004)Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial
BMJ : British Medical Journal, 329
P. Beaulieu (2006)Effects of nabilone, a synthetic cannabinoid, on postoperative pain
Canadian Journal of Anesthesia, 53
D. Wade, P. Robson, Heather House, P. Makela, J. Aram (2003)A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms
Clinical Rehabilitation, 17
A. Dogrul, M. Seyrek, B. Yalcin, A. Ulugol (2012)Involvement of descending serotonergic and noradrenergic pathways in CB1 receptor-mediated antinociception
Progress in Neuro-Psychopharmacology and Biological Psychiatry, 38
C. Hulsebosch (2012)Special Issue on microglia and chronic pain
Experimental Neurology, 234
F. Leweke, D. Piomelli, D. Piomelli, F. Pahlisch, F. Pahlisch, D. Muhl, D. Muhl, C. Gerth, C. Hoyer, C. Hoyer, J. Klosterkötter, M. Hellmich, D. Koethe, D. Koethe (2012)Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
Translational Psychiatry, 2
J. Zajicek, H. Sanders, D. Wright, P. Vickery, Wendy Ingram, S. Reilly, A. Nunn, L. Teare, P. Fox, A. Thompson (2005)Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up
Journal of Neurology, Neurosurgery & Psychiatry, 76
C. Michalski, F. Oti, M. Erkan, D. Sauliunaite, F. Bergmann, P. Pacher, S. Batkai, M. Müller, N. Giese, H. Friess, J. Kleeff (2008)Cannabinoids in pancreatic cancer: Correlation with survival and pain
International Journal of Cancer, 122
R. Mechoulam, L. Parker, R. Gallily (2002)Cannabidiol: An Overview of Some Pharmacological Aspects
The Journal of Clinical Pharmacology, 42
Y. Gaoni, R. Mechoulam (1964)Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish
Journal of the American Chemical Society, 86
Ronald Ellis, Will Toperoff, F. Vaida, G. Brande, J. Gonzales, B. Gouaux, Heather Bentley, J Atkinson (2009)Smoked Medicinal Cannabis for Neuropathic Pain in HIV: A Randomized, Crossover Clinical Trial
M. Beltramo (2009)Cannabinoid type 2 receptor as a target for chronic - pain.
Mini reviews in medicinal chemistry, 9 1
S. Welch (1993)Blockade of cannabinoid-induced antinociception by norbinaltorphimine, but not N,N-diallyl-tyrosine-Aib-phenylalanine-leucine, ICI 174,864 or naloxone in mice.
The Journal of pharmacology and experimental therapeutics, 265 2
E. Rahn, A. Hohmann (2009)Cannabinoids as pharmacotherapies for neuropathic pain: From the bench to the bedside
L. Lemberger, H. Rowe (1975)Clinical pharmacology of nabilone, a cannabinol derivative
Clinical Pharmacology & Therapeutics, 18
F. Campbell, Martin TramŁr, D. Carroll, John Reynolds, A. Moore, H. McQuay, R. Moore (2001)Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review
BMJ : British Medical Journal, 323
Identification functional characterization of brainstem cannabinoid CB2 receptors.
C. Felder, K. Joyce, E. Briley, J. Mansouri, K. Mackie, O. Blond, Y. Lai, A. Ma, R. Mitchell (1995)Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors.
Molecular pharmacology, 48 3
J. Walczak, V. Pichette, F. Leblond, K. Desbiens, P. Beaulieu (2005)Behavioral, pharmacological and molecular characterization of the saphenous nerve partial ligation: A new model of neuropathic pain
Moshe Zutler, J. Holty (2011)Opioids, sleep, and sleep-disordered breathing.
Current pharmaceutical design, 17 15
J. Gertsch, R. Pertwee, V. Marzo (2010)Phytocannabinoids beyond the Cannabis plant – do they exist?
British Journal of Pharmacology, 160
D. Richardson, R. Pearson, N. Kurian, M. Latif, M. Garle, D. Barrett, D. Kendall, B. Scammell, A. Reeve, V. Chapman, V. Chapman (2008)Characterisation of the cannabinoid receptor system in synovial tissue and fluid in patients with osteoarthritis and rheumatoid arthritis
Arthritis Research & Therapy, 10
M. Ibrahim, F. Porreca, J. Lai, P. Albrecht, F. Rice, A. Khodorova, G. Davar, A. Makriyannis, T. Vanderah, H. Mata, T. Malan (2005)CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids.
Proceedings of the National Academy of Sciences of the United States of America, 102 8
M. Naef, M. Curatolo, S. Petersen‐Felix, L. Arendt-Nielsen, A. Zbinden, R. Brenneisen (2003)The analgesic effect of oral delta-9-tetrahydrocannabinol (THC), morphine, and a THC-morphine combination in healthy subjects under experimental pain conditions
H. Brill (1981)Marihuana: The First Twelve Thousand Years.
Journal of psychoactive drugs, 13 4
M. Brusberg, S. Arvidsson, Daiwu Kang, H. Larsson, E. Lindström, V. Martínez (2009)CB1 Receptors Mediate the Analgesic Effects of Cannabinoids on Colorectal Distension-Induced Visceral Pain in Rodents
The Journal of Neuroscience, 29
A. Holdcroft, M. Smith, A. Jacklin, H. Hodgson, B. Smith, M. Newton, F. Evans (1997)Pain relief with oral cannabinoids in familial Mediterranean fever
D. Cichewicz, Erin Mccarthy (2003)Antinociceptive synergy between delta(9)-tetrahydrocannabinol and opioids after oral administration.
The Journal of pharmacology and experimental therapeutics, 304 3
W. Rice, J. Shannon, F. Burton, D. Fiedeldey (1997)Expression of a brain-type cannabinoid receptor (CB1) in alveolar Type II cells in the lung: regulation by hydrocortisone.
European journal of pharmacology, 327 2-3
Ittai Bushlin, R. Rozenfeld, L. Devi (2010)Cannabinoid-opioid interactions during neuropathic pain and analgesia.
Current opinion in pharmacology, 10 1
D. Gieringer, S. Goodrich (2004)Cannabis Vaporizer Combines Efficient Delivery of THC with Effective Suppression of Pyrolytic Compounds
(2014)Curr Pain Headache Rep
M. Lévesque (1986)Perception
The Yale Journal of Biology and Medicine, 59
M. Glass, R. Faull, M. Dragunow (1997)Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain
D. Wade, Petra Mäkelä, Heather House, C. Bateman, Philip Robson (2006)Long-term use of a cannabis-based medicine in the treatment of spasticity and other symptoms in multiple sclerosis
Multiple Sclerosis, 12
T. Nurmikko, M. Serpell, B. Hoggart, P. Toomey, B. Morlion, D. Haines (2007)Sativex successfully treats neuropathic pain characterised by allodynia: A randomised, double-blind, placebo-controlled clinical trial
L. Iversen, V. Chapman (2002)Cannabinoids: a real prospect for pain relief?
Current opinion in pharmacology, 2 1
Joanna Cohen (2001)Universities and tobacco money
BMJ : British Medical Journal, 323
M. Beltramo, N. Bernardini, R. Bertorelli, Marilena Campanella, Elisa Nicolussi, S. Fredduzzi, A. Reggiani (2006)CB2 receptor‐mediated antihyperalgesia: possible direct involvement of neural mechanisms
European Journal of Neuroscience, 23
J. Gertsch, M. Leonti, Stefan Raduner, I. Rácz, Jian-zhong Chen, X. Xie, K. Altmann, M. Karsak, A. Zimmer (2008)Beta-caryophyllene is a dietary cannabinoid
Proceedings of the National Academy of Sciences, 105
D. Abrams, C. Jay, S. Shade, H. Vizoso, Haatem Reda, S. Press, M. Kelly, M. Rowbotham, K. Petersen (2007)Cannabis in painful HIV-associated sensory neuropathy
W. Xiong, Tanxing Cui, K. Cheng, Fei Yang, Shaorui Chen, D. Willenbring, Y. Guan, H. Pan, Ke Ren, Yan Xu, Li Zhang (2012)Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors
The Journal of Experimental Medicine, 209
(2003)condi - tions
D. Buggy, L. Toogood, S. Maric, P. Sharpe, D. Lambert, D. Rowbotham (2003)Lack of analgesic efficacy of oral δ-9-tetrahydrocannabinol in postoperative pain
A. Mandavilli (2003)Marijuana researchers reach for pot of gold
Nature Medicine, 9
J. Berman, C. Symonds, R. Birch (2004)Efficacy of two cannabis based medicinal extracts for relief of central neuropathic pain from brachial plexus avulsion: results of a randomised controlled trial
M. Iskedjian, B. Bereza, A. Gordon, C. Piwko, T. Einarson (2007)Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain
Current Medical Research and Opinion, 23
K. Starowicz, N. Malek, B. Przewłocka (2013)Cannabinoid receptors and pain
E. Ishac, Liu Jiang, K. Lake, K. Varga, M. Abood, G. Kunos (1996)Inhibition of exocytotic noradrenaline release by presynaptic cannabinoid CB 1 receptors on peripheral sympathetic nerves
British Journal of Pharmacology, 118
(2003)J Pharmacol Exp Ther
C. Dinarello (2009)Immunological and inflammatory functions of the interleukin-1 family.
Annual review of immunology, 27
C. Felder, A. Nielsen, E. Briley, M. Palkovits, J. Priller, J. Axelrod, Duy Nguyen, J. Richardson, R. Riggin, G. Koppel, S. Paul, G. Becker (1996)Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat
FEBS Letters, 393
S. Galiègue, S. Mary, J. Marchand, D. Dussossoy, D. Carrière, P. Carayon, M. Bouaboula, D. Shire, G. Fur, P. Casellas (1995)Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations.
European journal of biochemistry, 232 1
D. Buggy, L. Toogood, S. Maric, P. Sharpe, D. Lambert, D. Rowbotham (2003)Lack of analgesic efficacy of oral delta-9-tetrahydrocannabinol in postoperative pain.
Pain, 106 1-2
R Adams (1940)Marihuana
B. Wilsey, Thomas Marcotte, Alexander Tsodikov, Jeanna Millman, Heather Bentley, B. Gouaux, Scott Fishman (2008)A randomized, placebo-controlled, crossover trial of cannabis cigarettes in neuropathic pain.
The journal of pain : official journal of the American Pain Society, 9 6
C. Morgan, H. Curran (2008)Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis
British Journal of Psychiatry, 192
G. Edwards (1975)Marihuana
Joe Zlas, H. Stark, J. Seligman, Rina Levy, E. Werker, A. Breuer, R. Mechoulam (1993)Early medical use of cannabis
M. Jhaveri, D. Sagar, S. Elmes, D. Kendall, V. Chapman (2007)Cannabinoid CB2 Receptor-Mediated Anti-nociception in Models of Acute and Chronic Pain
Molecular Neurobiology, 36
R. Mechoulam (1970)Marihuana chemistry.
Science, 168 3936
R. Nicoll, B. Alger (2004)The brain's own marijuana.
Scientific American, 291 6
M. Mikuriya (2007)Marijuana: Medical Papers, 1839-1972
L. Petrocellis, T. Bisogno, M. Maccarrone, John Davis, A. Finazzi-Agrò, V. Marzo (2001)The Activity of Anandamide at Vanilloid VR1 Receptors Requires Facilitated Transport across the Cell Membrane and Is Limited by Intracellular Metabolism*
The Journal of Biological Chemistry, 276
R. Skrabek, L. Galimova, K. Ethans, Daryl Perry (2008)Nabilone for the treatment of pain in fibromyalgia.
The journal of pain : official journal of the American Pain Society, 9 2
A. Thomas, G. Baillie, A. Phillips, R. Razdan, R. Ross, R. Pertwee (2007)Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro
British Journal of Pharmacology, 150
G. Wotherspoon, A. Fox, P. McIntyre, Sian Colley, S. Bevan, J. Winter (2005)Peripheral nerve injury induces cannabinoid receptor 2 protein expression in rat sensory neurons
W. Notcutt, M. Price, Roy Miller, Samantha Newport, Cheryl Phillips, Susan Simmons, C. Sansom (2004)Initial experiences with medicinal extracts of cannabis for chronic pain: Results from 34 ‘N of 1’ studies
M. Karst, K. Salim, S. Burstein, I. Conrad, L. Hoy, U. Schneider (2003)Analgesic effect of the synthetic cannabinoid CT-3 on chronic neuropathic pain: a randomized controlled trial.
JAMA, 290 13
P. Smith, D. Compton, S. Welch, R. Razdan, R. Mechoulam, B. Martin (1994)The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice.
The Journal of pharmacology and experimental therapeutics, 270 1
(2008)Anti-inflammatory cannabinoids in diet: towards a better understanding of CB(2) receptor action
Treatment options for neuropathic pain have limited efficacy and use is fraught with dose-limiting adverse effects. The endocannabinoid system has been elucidated over the last several years, demonstrating a significant interface with pain homeostasis. Exogenous cannabinoids have been demonstrated to be effective in a range of experimental neuropathic pain models, and there is mounting evidence for therapeutic use in human neuropathic pain conditions. This article reviews the history, pharmacologic development, clinical trials results, and the future potential of nonsmoked, orally bioavailable, nonpsychoactive cannabinoids in the management of neuropathic pain.
Current Pain and Headache Reports – Springer Journals
Published: Aug 28, 2014
Access the full text.
Sign up today, get DeepDyve free for 14 days.